Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Brain Neoplasms 5Squamous Cell Carcinoma of Head and Neck 4Polycythemia Vera 4Glioblastoma 4Meningioma 3Leukemia, Myeloid, Acute 3Pharyngeal Neoplasms 2Paranasal Sinus Neoplasms 2Neoplasms 2Laryngeal Neoplasms 2Head and Neck Neoplasms 2Gliosarcoma 2Thrombocytosis 1Thrombocythemia, Essential 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Papillomavirus Infections 1Oropharyngeal Neoplasms 1Nose Neoplasms 1Myeloproliferative Disorders 1Myelodysplastic Syndromes 1Lymphoma, Non-Hodgkin 1Hodgkin Disease 1Glioma 1Epstein-Barr Virus Infections 1Carcinoma, Squamous Cell 1Carcinoma 1Astrocytoma 1Adenocarcinoma 1

Interventions

Rituximab 5Valganciclovir 2Methotrexate 2Leucovorin 2Doxorubicin 2valomaciclovir 1threonic acid 1pembrolizumab 1otelixizumab 1merphos 1cc-486 1avelumab 1Zidovudine 1Vincristine 1Valacyclovir 1Tomography, X-Ray Computed 1Prednisone 1Magnesium Sulfate 1Interferons 1Hydroxyurea 1Etoposide 1Echocardiography 1EPOCH protocol 1Cyclophosphamide 1Caves 1Carboplatin 1Brentuximab Vedotin 1Bortezomib 1Azacitidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Epstein-Barr Virus Infections × Hydroxyurea × Clear all
NCT01964755 2019-09-23

Chemotherapy for Relapsed Epstein Barr Virus Associated Lymphoma

University of Miami

Phase 2 Terminated
6 enrolled 14 charts
Lymphoid

Hodgkin Disease, Lymphoma, Non-Hodgkin, Epstein-Barr Virus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡